|5.76||+0.07 / +1.23%|
As of 1:00pm ET
|5.76||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +73.61% increase from the last price of 5.76.
The current consensus among 4 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.